Showing results (1-10 of 28) with videos related to
Sort By:
Pageof 3
Hematology. American Society of Hematology. Education Program|December 10, 2013
Novel therapy for Hodgkin lymphomaConnie Lee Batlevi, Anas YounesCurrent Opinion in Hematology|May 21, 2019
Using genomic data for selecting the treatment of lymphoma patientsConnie Lee Batlevi, Gunjan Shah, Christopher Forlenza, et al.Nature Reviews. Clinical Oncology|November 4, 2015
Novel immunotherapies in lymphoid malignanciesConnie Lee Batlevi, Eri Matsuki, Renier J Brentjens, et al.Blood Advances|April 29, 2020
Baseline FDG-PET/CT detects bone marrow involvement in follicular lymphoma and provides relevant prognostic informationReiko Nakajima, Alison J Moskowitz, Laure Michaud, et al.Blood Reviews|July 19, 2022
Taking the EZ way: Targeting enhancer of zeste homolog 2 in B-cell lymphomasFranck Morschhauser, Gilles Salles, Connie Lee Batlevi, et al.JCI Insight|June 21, 2019
Noncovalent inhibitors reveal BTK gatekeeper and auto-inhibitory residues that control its transforming activityShenqiu Wang, Sayan Mondal, Chunying Zhao, et al.Haematologica|May 7, 2016
ENGAGE- 501: phase II study of entinostat (SNDX-275) in relapsed and refractory Hodgkin lymphomaConnie Lee Batlevi, Yvette Kasamon, R Gregory Bociek, et al.Cold Spring Harbor Molecular Case Studies|August 10, 2019
Divergent clonal evolution of a common precursor to mantle cell lymphoma and classic Hodgkin lymphomaHammad Tashkandi, Kseniya Petrova-Drus, Connie Lee Batlevi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 6, 2026
Polatuzumab Vedotin Plus Rituximab, Gemcitabine, and Oxaliplatin in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Results From the Phase III, Randomized POLARGO TrialMatthew Matasar, Zhiming Li, Theodoros P Vassilakopoulos, et al.Blood Advances|March 14, 2025
Subgroup analysis of older patients ≥60 years with diffuse large B-cell lymphoma in the phase 3 POLARIX studyBei Hu, Patrick M Reagan, Laurie H Sehn, et al.Pageof 3